FOMDWebPartPage

Division of Maternal-Fetal Medicine

Research in the Division of Maternal-Fetal Medicine (MFM) has grown exponentially. This has occurred in both basic sciences and clinical investigation.​

The MFM Division has strong clinical research collaborations with several clinical departments in the Faculty of Medicine & Dentistry at the University of Alberta. These include the departments of Pediatrics, Radiology & Diagnostic Imaging, and Laboratory Medicine & Pathology.

The MFM Division has also been involved in several Canadian multicentre trials over the years, both as a participating centre and more recently as a lead centre. There have been several areas of clinical research focus, including:  prenatal diagnosis, pregnancy management, and pregnancy/neonatal/infant outcomes.
 
Examples of significant clinical research collaborations include:
  • Lee J. Brewerton, B.Sc.; Radha S. Chari, MD, FRCSC; Yuanyuan Liang, M.Sc.; and Ravi Bhargava, MD, FRCPC. Publication for  standards for normal MRI fetal lung/liver intensities during gestation; fetal lung-to-liver signal intensity ratio at MR imaging:  Development of a normal scale and possible role in predicting pulmonary hypoplasia in utero. June 2005 Radiology, 235, 1005-1010.
  • Emerging Team Grant:
    Kozyrskyj, Anita L.; Becker, Allan B.; Guttman, David S.; Hayglass, Kent T.; Mandhane, Piush; Scott, James A.;  Befus, A.D.; Chari, Radha S.; Field, Catherine J.; Klassen, Terry P.; Moqbel, Redwan; Turvey, Stuart E.  Synergy in Microbiota Research (SyMBIOTA). University of Alberta/Canadian Institutes of Health Research - Emerging Team Grant: Canadian Microbiome Initiative – May 2010.
  • An Edmonton-based Canadian multicentre randomized trial:
    R. S. Chari; F. Audibert; E. Bujold; S. Wood; S. Mentaclou; M. Helewa; G. Marquette; C. Hoskins; N. Schuurmans; G. Black; L. Russell; J. Martel; B. Devrijer; B. Vandermeer; R. Watts; T. Lacaze-Masmonteil. Intentional delivery versus expectant management in women with preterm and prelabour rupture of the membranes (PPROM) between 32 and 35 weeks: A multicentre, randomized, controlled trial. Abstract accepted for Oral Presentation at the annual clinical meeting of the Society of Obstetricians and Gynaecologists of Canada (SOGC) Annual Clinical Meeting, Vancouver, June 2011.

For information about this division's clinical activities, please visit this page.